http://money.cnn.com/news/newsfeeds/articles/apwire/51b5a704d9408656d7ac7cf8b45b174b.htm NEW YORK (Associated Press) - A day after Baxter International Inc. recalled nearly all remaining batches of its blood thinner heparin, a report Friday linked the product to additional patient deaths.
Late Thursday, Baxter said it will recall all remaining lots of heparin single- and multi-dose injections and HEP-LOCK products. The company recalled nine production lots of heparin multi-dose injection in January after the drug was linked to four deaths and hundreds of allergic reactions.
On Friday, the New York Times reported that the Food and Drug Administration had discovered possible links to 17 other deaths. The paper added that the agency is focusing on a Chinese plant that supplies the active ingredient in heparin, which is made from mucous membranes extracted from pig intestines.
In a letter posted to the FDA Web site Thursday, the FDA discussed problems in the manufacturing process. It said some lots of heparin sold in the U.S. "included material from an unacceptable workshop vendor," among other issues.